Clinical Trial Update: Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study [Phase 4]

View source ↗

Summary

A randomized, placebo-controlled Phase 4 trial evaluated lysozyme for reducing acute exacerbations in chronic obstructive pulmonary disease. The study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Lysozyme (lysozyme)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: COPD | Phase 4 | Status: COMPLETED